dehydroepiandrosterone has been researched along with phenylephrine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Akamine, EH; Camporez, JP; Carvalho, CR; Davel, AP; Franci, CR; Rossoni, LV | 1 |
Baines, CP; Douglas, DL; Krenz, M; McCommis, KS | 1 |
3 other study(ies) available for dehydroepiandrosterone and phenylephrine
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Dehydroepiandrosterone protects against oxidative stress-induced endothelial dysfunction in ovariectomized rats.
Topics: Acetophenones; Acetylcholine; Animals; Aorta, Thoracic; Cardiovascular Agents; Dehydroepiandrosterone; Endothelium, Vascular; Female; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase Type III; Nitroprusside; Ovariectomy; Oxidative Stress; Phenylephrine; Rats; Rats, Wistar; Reactive Oxygen Species; Superoxide Dismutase | 2011 |
Cardiac-specific hexokinase 2 overexpression attenuates hypertrophy by increasing pentose phosphate pathway flux.
Topics: Adrenergic alpha-Agonists; Animals; Animals, Newborn; Cardiomegaly; Cell Death; Cells, Cultured; Dehydroepiandrosterone; Disease Models, Animal; Enzyme Inhibitors; Female; Glucosephosphate Dehydrogenase; Hexokinase; Isoproterenol; Male; Mice; Mice, Transgenic; Myocytes, Cardiac; Oxidative Stress; Pentose Phosphate Pathway; Phenylephrine; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; RNA Interference; Time Factors; Transfection | 2013 |